Publisher
Springer Science and Business Media LLC
Reference22 articles.
1. Siegel RL, Miller KA, Wagle NS, Jemal A (2023) Cancer statistics, 2023. CA A Cancer J Clin 73(1):17–48
2. Garfield K, LaGrange CA (2024) Renal Cell Cancer. [Updated 2023 Jul 31]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing
3. Padala SA, Barsouk A, Thandra KC, Saginala K, Mohammed A, Vakiti A, Rawla P, Barsouk A (2020) Epidemiology of renal cell carcinoma. World J Oncol 11(3):79–87
4. McDermott DF, Regan MM, Clark JI et al (2005) Randomized phase III trial of high-dose interleukin-2 versus subcutaneous ınterleukin-2 and interferon in patients with metastatic renal cell carcinoma. J Clin Oncol 23(1):133–141
5. Motzer RJ, Hutson TE, Cella D et al (2013) Pazopanib versus sunitinib in metastatic renal-cell carcinoma. N Engl J Med 369(8):722–731